<DOC>
<DOCNO>
EP-0013901
</DOCNO>
<TEXT>
<DATE>
19800806
</DATE>
<IPC-CLASSIFICATIONS>
<main>A61K-39/395</main> A61K-39/395 C07G-7/00 
</IPC-CLASSIFICATIONS>
<TITLE>
process of preparation of an intravenous immunoglobulin solution, containing concentrated igm.
</TITLE>
<APPLICANT>
biotest serum institut gmbhde <sep>biotest-serum-institut gmbh <sep>biotest-serum-institut gmbhflughafenstrasse 4d-6000 frankfurt-niederradde<sep>biotest-serum-institut gmbh <sep>
</APPLICANT>
<INVENTOR>
stephan wolfgang dr-dipl-chem<sep>stephan, wolfgang, dr.-dipl.-chem.<sep>stephan, wolfgang, dr.-dipl.-chem.philipp-holzmann-strasse 84d-6072 dreieichde<sep>stephan, wolfgang, dr.-dipl.-chem.<sep>stephan, wolfgang, dr.-dipl.-chem. philipp-holzmann-strasse 84 d-6072 dreieich de<sep>
</INVENTOR>
<ABSTRACT>
The invention relates to a method for producing an immune globulin solution suitable for intravenous application, which contains IgM in concentrated form, which is characterized by a IgM-containing protein fraction obtained by a known fractionation method of blood plasma or serum with such amounts of β-propiolactoneTreated that the ratio of β-propiolactone to a 5% solution of the IgM containing proteins is 0.05 to 0.15 ml per 100 ml, and then processed in a known manner.As outgoing material, IgM-containing fractions of the Cohn 's alcohol fractionation or the Rivanol Ammonsul Fat fractionation of human blood plasma can be used.
</ABSTRACT>
</TEXT>
</DOC>
